Karolinska Institutet, Karolinska University Hospital, and SciLifeLab integrated whole genome sequencing into routine rare-disease diagnostics at Karolinska University Hospital. The initiative reportedly sequenced the full genomes of more than 15,000 patients, updating the diagnostic workflow for clinical use. The reporting emphasizes operational scale and institutional integration rather than a single clinical trial result, with the outcome being broader access to genomic testing and improved diagnosis yield for rare conditions. For biotech operators, the news reflects accelerating adoption of WGS as infrastructure—supporting downstream test standardization, lab automation needs, and future opportunities for variant interpretation tools and clinical decision support systems.